[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346660-105":59,"doc-detail-346660-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploiting-synthetic-lethality-in-epithelial-ovarian-cancer-multi-dimensional-approaches-beyond-dna-damage-repair","Exploiting synthetic lethality in epithelial ovarian cancer: multi-dimensional approaches beyond DNA damage repair","","Synthetic lethality (SL) is a targeted cancer therapy concept that selectively eliminates tumor cells by disrupting two interdependent molecular vulnerabilities that become jointly essential for survival. PARP inhibitors have transformed treatment of homologous recombination repair–deficient breast and ovarian cancers, but resistance is widespread, motivating SL expansion beyond canonical DNA repair targets. Severe DNA lesions activate the DNA damage response (DDR), generating additional SL opportunities. For epithelial ovarian cancer, late detection and treatment resistance create a setting to combine multiple targets and drive durable, personalized therapeutic responses by linking DDR signaling, cell-cycle control, metabolism, epigenetics, and fate decisions such as apoptosis or senescence.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploiting-synthetic-lethality-in-epithelial-ovarian-cancer-multi-dimensional-approaches-beyond-dna-damage-repair/346660/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploiting-synthetic-lethality-in-epithelial-ovarian-cancer-multi-dimensional-approaches-beyond-dna-damage-repair/346660.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does synthetic lethality mean in this review?","Question",{"text":112,"@type":113},"Synthetic lethality targets cancer cells by disrupting two interdependent molecular targets that become essential together for cancer cell survival.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why are strategies beyond classical DNA repair targets needed?",{"text":117,"@type":113},"Resistance to current SL approaches, including PARP inhibitors, is nearly universal, motivating SL expansion to additional vulnerabilities.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biological processes are integrated in the proposed multidimensional approaches?",{"text":121,"@type":113},"The review emphasizes interplay among DDR signaling, cell-cycle regulation, metabolism, epigenetics, and downstream cell fate decisions such as apoptosis or senescence.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346660,1790185619,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Bigdeli etal. Molecular Cancer (2026) 25:72 Molecular Cancer  \n[https://doi.org/10.1186/s12943-025-02562-w](https://doi.org/10.1186/s12943-025-02562-w)  \nREVIEW Open Access  \nExploiting synthetic lethality in epithelial  ovarian cancer: multi-dimensional approaches beyond DNA damage repair  \nMandana Bigdeli1,2, Elizabeth Tremblay1,2,3, Diane Provencher1,2,3, Anne-Marie Mes-Masson 1,2,4 and Francis Rodier1,2,5*  \nAbstract  \nSynthetic lethality (SL) is a therapeutic approach that selectively target cancer cells via the disruption of two interdependent molecular targets, which together become essential in the cancer context to ensure cancer cell survival. Among anticancer SL strategies, poly ADP-ribose polymerase (PARP) inhibitors have revolutionized the treatment of homologous recombination repair deficient breast and ovarian cancers by targeting the remaining DNA repair mechanisms. However, resistance emergence is nearly universal providing the rationale to expand beyond classical DNA repair targets. Severe DNA lesions like double-strand breaks or extended single-strand stretches trigger the complex DNA damage response signaling cascade (DDR), which provides many SL targets in addition to direct DNA repair mechanisms. Epithelial ovarian cancer is the deadliest gynecologic malignancy, in part because of late detection and treatment resistance, which provides a rich environment to explore the concept of combining multiple targets to produce SL synergies that kill cancer cells. In this context we discuss the interplay among varied components of the DDR including DNA damage signalers, cell cycle regulation, metabolism, epigenetics, and subsequent cell fate decisions like apoptosis or senescence. Based on this knowledge we further explore innovative SL approaches that may elicit or restore drug sensitivity in resistant tumors. Overall, we provide the rationale for multidimensional strategies linking classic DNA repair mechanisms to various molecular vulnerabilities sometimes apparently unrelated or downstream from DNA damage to improve cancer treatment outcomes via more effective and durable therapeutic responses, offering additional options for the personalized treatment of this highly heterogeneous disease.  \nKeywords Epithelial ovarian cancer, Drug resistance, Cell fate decisions, Metabolism, DNA Repair Graphical Abstract  \nMulti-dimensional synthetic lethality leverages interconnected vulnerabilities in DNA repair, metabolism, epigenetics, and cell cycle regulation to selectively eliminate ovarian cancer cells. Combining DNA damage response (DDR) disruption with metabolic and epigenetic targeting drives cancer cell death and limits resistance.  \n*Correspondence: Francis Rodier [rodierf@mac.com](rodierf@mac.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nBigdeli et al. Molec","cbCaitLkwtZwk2cS","https://ap.wps.com/l/cbCaitLkwtZwk2cS","pdf",1798467,16,"English","# Introduction\n## Synthetic lethality concept and therapeutic rationale\n## DDR-driven SL targets beyond direct DNA repair\n## PARP inhibitors and the challenge of resistance\n## Rationale for multidimensional SL strategies in epithelial ovarian cancer","[{\"question\":\"What does synthetic lethality mean in this review?\",\"answer\":\"Synthetic lethality targets cancer cells by disrupting two interdependent molecular targets that become essential together for cancer cell survival.\"},{\"question\":\"Why are strategies beyond classical DNA repair targets needed?\",\"answer\":\"Resistance to current SL approaches, including PARP inhibitors, is nearly universal, motivating SL expansion to additional vulnerabilities.\"},{\"question\":\"Which biological processes are integrated in the proposed multidimensional approaches?\",\"answer\":\"The review emphasizes interplay among DDR signaling, cell-cycle regulation, metabolism, epigenetics, and downstream cell fate decisions such as apoptosis or senescence.\"}]","Exploiting synthetic lethality in epithelial ovarian cancer: multi-dimensional approaches beyond DNA damage repair | PDF",1790062316,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70921addf935e98e832293938b63158d.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb39f73fd6a4ddea6092d09ffea90fdd.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f240e350faa34826b36724d1be74080f.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/779867080221ef755584eee899a53ad1.webp",980,1306]